Literature DB >> 12003703

Antihypertensive drugs and cognitive function.

Anne-Sophie Rigaud1, M G M Olde-Rikkert, Olivier Hanon, Marie-Laure Seux, Françoise Forette.   

Abstract

The increase in life expectancy is associated with a sharp rise in cognitive disorders, particularly after the age of 80 years. The identification and management of risk factors for these invalidating and distressing conditions must be considered a priority. Hypertension has been shown to carry an increased risk not only for cerebrovascular morbidity and mortality, but also for cognitive impairment and dementia. The fact that antihypertensive treatment has been demonstrated to decrease those risks offers a new opportunity to reduce the prevalence of such related disorders and to promote healthy aging.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12003703     DOI: 10.1007/s11906-002-0009-2

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  35 in total

1.  Midlife blood pressure and dementia: the Honolulu-Asia aging study.

Authors:  L J Launer; G W Ross; H Petrovitch; K Masaki; D Foley; L R White; R J Havlik
Journal:  Neurobiol Aging       Date:  2000 Jan-Feb       Impact factor: 4.673

Review 2.  The European Working Party on High Blood Pressure in the Elderly.

Authors:  A Amery; A De Schaepdryver
Journal:  Am J Med       Date:  1991-03       Impact factor: 4.965

Review 3.  Antihypertensive medications and depression.

Authors:  M H Beers; L J Passman
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

4.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Authors:  J A Staessen; R Fagard; L Thijs; H Celis; G G Arabidze; W H Birkenhäger; C J Bulpitt; P W de Leeuw; C T Dollery; A E Fletcher; F Forette; G Leonetti; C Nachev; E T O'Brien; J Rosenfeld; J L Rodicio; J Tuomilehto; A Zanchetti
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

5.  15-year longitudinal study of blood pressure and dementia.

Authors:  I Skoog; B Lernfelt; S Landahl; B Palmertz; L A Andreasson; L Nilsson; G Persson; A Odén; A Svanborg
Journal:  Lancet       Date:  1996-04-27       Impact factor: 79.321

6.  Calcium-channel blockers and cognitive function in elderly people: results from the Canadian Study of Health and Aging.

Authors:  C J Maxwell; D B Hogan; E M Ebly
Journal:  CMAJ       Date:  1999-09-07       Impact factor: 8.262

Review 7.  Hypertension in very old subjects.

Authors:  B Forette
Journal:  Clin Exp Hypertens       Date:  1999 Jul-Aug       Impact factor: 1.749

8.  Preexisting dementia in stroke patients. Baseline frequency, associated factors, and outcome.

Authors:  H Hénon; F Pasquier; I Durieu; O Godefroy; C Lucas; F Lebert; D Leys
Journal:  Stroke       Date:  1997-12       Impact factor: 7.914

9.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

10.  Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults.

Authors:  M J Prince; A S Bird; R A Blizard; A H Mann
Journal:  BMJ       Date:  1996-03-30
View more
  2 in total

Review 1.  Hypertension and cognitive function: pathophysiologic effects of hypertension on the brain.

Authors:  Teri A Manolio; Jean Olson; W T Longstreth
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

2.  Simvastatin therapy attenuates memory deficits that associate with brain monocyte infiltration in chronic hypercholesterolemia.

Authors:  Nicholas Don-Doncow; Lotte Vanherle; Frank Matthes; Sine Kragh Petersen; Hana Matuskova; Sara Rattik; Anetta Härtlova; Anja Meissner
Journal:  NPJ Aging Mech Dis       Date:  2021-08-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.